Mapping Molecular Discordance in the Brain
Single-cell proteomics reveals cell-type-specific regulation invisible to RNA-based methods
Clinical Scorecard: Mapping Molecular Discordance in the Brain
At a Glance
Category Detail
Condition Neurodevelopmental Disorders Key Mechanisms Post-transcriptional regulation of protein expression Target Population Prenatal human brain tissue Care Setting Research laboratories
Key Highlights
Single-cell proteomics reveals discordance between gene expression and protein abundance. Direct measurement of protein levels without antibody reliance enhances cellular identity understanding. Key developmental transitions linked to neurodevelopmental vulnerability identified. High-risk genes show high transcript levels but low protein abundance, indicating regulatory buffering. Potential for insights into neurodevelopmental disorders through protein regulation analysis. Guideline-Based Recommendations
Diagnosis
Utilize single-cell proteomics to assess protein expression in neurodevelopmental contexts. Management
Integrate proteomic data with genetic and functional analyses for comprehensive understanding. Monitoring & Follow-up
Track protein expression changes across developmental stages to identify risk factors. Risks
Consider the implications of post-transcriptional regulation in neurodevelopmental disorders. Patient & Prescribing Data
Individuals at risk for neurodevelopmental disorders, particularly during prenatal development.
Understanding protein regulation may inform therapeutic strategies for neurodevelopmental conditions.
Clinical Best Practices
Apply single-cell proteomics to various developmental stages for broader insights. Combine proteomic findings with genetic data to elucidate mechanisms of neurodevelopmental disorders. References
